We are live on ! Find out more
AllianceBernstein

AllianceBernstein Portfolio holdings

AUM $309B
1-Year Est. Return 23.92%
 

AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.

This Fund
S&P 500
This Quarter Est. Return
+25.15%
1 Year Est. Return
+23.92%
3 Year Est. Return
+92.38%
5 Year Est. Return
+118.97%
10 Year Est. Return
+515.32%
AUM
$170B
AUM Growth
+$30.7B
Cap. Flow
-$126M
Cap. Flow %
-0.07%
Top 10 Hldgs %
23.29%
Holding
3,348
New
216
Increased
1,761
Reduced
1,112
Closed
154

Top Buys

Rank Stock Value
1
OTIS icon
Otis Worldwide
OTIS
+$323M
2
V icon
Visa
V
+$288M
3
RTX icon
RTX Corp
RTX
+$262M
4
ACM icon
Aecom
ACM
+$250M
5
ADP icon
Automatic Data Processing
ADP
+$215M

Sector Composition

Rank Sector Weight
1 Technology 22.48%
2 Healthcare 16.91%
3 Financials 12.2%
4 Consumer Discretionary 11.74%
5 Communication Services 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KIN
3001
DELISTED
Kindred Biosciences, Inc.
KIN
$202K ﹤0.01%
45,100
+9,000
+25% +$40.2K
IHC
3002
DELISTED
Independence Holding Company
IHC
$201K ﹤0.01%
+6,563
New +$183K
PHAS
3003
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$200K ﹤0.01%
+43,500
New +$193K
MNOV icon
3004
MediciNova
MNOV
$64.5M
$199K ﹤0.01%
36,800
+7,700
+26% +$40.8K
SNCR
3005
DELISTED
Synchronoss Technologies
SNCR
$198K ﹤0.01%
6,233
+2,422
+64% +$66.8K
NH
3006
DELISTED
NantHealth, Inc
NH
$196K ﹤0.01%
+2,860
New +$114K
VRCA icon
3007
Verrica Pharmaceuticals
VRCA
$91M
$195K ﹤0.01%
1,770
+430
+32% +$49.7K
WNEB icon
3008
Western New England Bancorp
WNEB
$289M
$195K ﹤0.01%
33,700
+3,500
+12% +$19.4K
PBR.A icon
3009
Petrobras Class A
PBR.A
$104B
$194K ﹤0.01%
24,307
-8,177
-25% -$57.4K
USX
3010
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$193K ﹤0.01%
32,200
+4,300
+15% +$19.6K
AMSC icon
3011
American Superconductor
AMSC
$1.45B
$192K ﹤0.01%
23,600
+7,600
+48% +$49.7K
VTOL icon
3012
Bristow Group
VTOL
$1.36B
$191K ﹤0.01%
13,738
-1,512
-10% -$16.1K
PVLA
3013
Palvella Therapeutics
PVLA
$2.04B
$191K ﹤0.01%
771
+158
+26% +$36.9K
SLDB icon
3014
Solid Biosciences
SLDB
$788M
$190K ﹤0.01%
4,327
+660
+18% +$27.4K
HMTV
3015
DELISTED
Hemisphere Media Group, Inc.
HMTV
$185K ﹤0.01%
18,800
+2,600
+16% +$23.8K
ENZ
3016
DELISTED
Enzo Biochem, Inc.
ENZ
$183K ﹤0.01%
81,900
+22,000
+37% +$56.6K
QUAD icon
3017
Quad
QUAD
$446M
$182K ﹤0.01%
55,900
+20,600
+58% +$63.1K
CASI
3018
DELISTED
CASI Pharmaceuticals
CASI
$181K ﹤0.01%
7,220
+1,320
+22% +$28.7K
GHM icon
3019
Graham Corp
GHM
$1.17B
$178K ﹤0.01%
14,000
+2,100
+18% +$25.7K
ROCC
3020
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$178K ﹤0.01%
18,650
-50
-0.3% -$387
MYF
3021
DELISTED
Blackrock Muni Yield Investment Fund, Inc.
MYF
$177K ﹤0.01%
13,189
CLFD icon
3022
Clearfield
CLFD
$417M
$175K ﹤0.01%
12,500
+1,100
+10% +$14.2K
LQDT icon
3023
Liquidity Services
LQDT
$1.2B
$175K ﹤0.01%
29,320
+8,470
+41% +$44.9K
SPRO icon
3024
Spero Therapeutics
SPRO
$70.1M
$172K ﹤0.01%
+12,734
New +$143K
KRMD icon
3025
KORU Medical Systems
KRMD
$180M
$170K ﹤0.01%
+18,900
New +$191K

Similar funds

AllianceBernstein's Q2 2020 Portfolio in Review

As of Q2 2020, AllianceBernstein held 3,348 positions worth $170B, up 22% from $139B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

AllianceBernstein's Q2 2020 filing shows 216 new, 1,761 increased, 1,112 reduced and 154 closed positions. Its largest new stake was Otis Worldwide: 6,236,857 shares worth $355M. The largest sale was Berkshire Hathaway Class B, an estimated $468M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • AllianceBernstein's largest Q2 2020 buy was Otis Worldwide: 6,236,857 shares worth $355M.
  • AllianceBernstein added most to Visa in Q2 2020, an estimated $288M increase.
  • AllianceBernstein's biggest Q2 2020 reduction was Berkshire Hathaway Class B, cutting an estimated $468M.
  • AllianceBernstein fully exited Raytheon Company in Q2 2020, selling an estimated $349M.
  • AllianceBernstein's ten largest holdings make up 23% of its $170B portfolio in Q2 2020.
  • AllianceBernstein opened 216 new positions and closed 154 in Q2 2020.
  • AllianceBernstein's portfolio value rose 22% quarter-over-quarter to $170B.

Based on AllianceBernstein's 13F filing for Q2 2020, filed 13 Aug 2020.